Validation Master Plan SOP
Validation Master Plan SOP
1.0 OBJECTIVE:
To lay down Standard Operating Procedure for “Validation master Plan”.
2.0 SCOPE:
This procedure is applicable for preparation, review, approval and authorization of Validation Master
Plan of ……….
3.0 RESPONSIBILITY:
QA (Officer/Executive): Shall be responsible Preparation, Distribution, Revision, Retrieval and
Destruction of this SOP.
Head QC: Shall be responsible for review of VMP.
Head Engineering: Shall be responsible for review of VMP.
QA (Executive/Manager): shall be responsible for review of VMP.
Head Quality Assurance: shall be responsible for approval of the VMP.
4.0 ACCOUNTABILITY:
Head-Quality Assurance shall be accountable for ensuring compliance of this Standard Operating
Procedure.
5.0 DEFINITION:
Validation Master Plan is defined as an overview of the entire validation operation, its organizational
structure, its content and planning. The core of VMP shall consist of the list of the items to be
validated
and the planning schedule.
6.0 PROCEDURE:
6.1 Validation program is designed to demonstrate that the facility for the production and storage of
Active Pharmaceutical Ingredient and its intermediate is capable of meeting process parameters in a
repeatable and controllable manner.
PharmaZonner
QUALITY ASSURANCE DEPARTMENT
6.2 Facility is designed to provide the necessary and required degree of environment and
manufacturing control for all production steps throughout the manufacturing process. Critical
utilities, processes and equipment validation program are established in accordance with the method
and procedures mandated by the product requirements which are based on the currently available
product information and the current Good Manufacturing Practices, guidelines and other
regulations.
6.3 All system is subject to ongoing validation to evaluate the impact of change in process, systems,
computers (software), environment, intentionally or un-intentionally
6.4 Validation studies as detailed in the protocol are carried out by nominated team comprising
personnel from various disciplines.
6.5 Qualification
➢ User requirement Specification: For any of the critical equipment user department shall
mention specification, which specifies the technical specification of the equipment or system,
regulatory specification, safety specification, documentary specification, engineering
specification. Details specified in the URS shall be mention in the protocol.
➢ Design Qualification:
Demonstrates that the proposed design of the facility, equipment, control system, utility and
selected components is suitable for intended purpose.
➢ Installation Qualification:
Demonstrates that the facility, equipment, control system, utility and selected components are
the ones installed as per the approved design, that they are at the specified locations, that they
are properly identified, that the required SOP’s exists, that operating manuals are on file and
that all the critical measuring devices are calibrated using an established calibration program
me.
➢ Operational Qualification:
Demonstrates that all facility, equipment, control system, utilities and the components of each
of the systems perform as intended throughout the anticipated operating ranges.
➢ Performance Qualification:
PharmaZonner
QUALITY ASSURANCE DEPARTMENT
➢ Demonstrates by the execution of a series of tests that the facility, equipment, control system
and utility used in the manufacturing process perform in a reproducible manner and meet the
pre-established specifications.
➢ The performance qualification will also include testing that demonstrates that all intermediate
and final product specifications can be met. This phase will be executed once the process
parameters have been defined.
6.6 Process Validation:
➢ Prospective Validation:
The Prospective validation should take care of the following:
Development report, Responsibilities, Process description, Equipment details, Equipment
Qualification, Equipment Calibration, Batch record, Validation protocols for specific
activities, Quality Control release specification, Sampling plan, Comparison of yields,
Process parameters and Quality parameters, evaluating results and responsibilities.
➢ Concurrent validation:
This is the Validation carried out during routine production. This validation comprises of
identification and evaluation of process (including critical process parameters) and quality
parameters applicable for the product. This should be performed on 3 consecutive batches.
At least one batch should be monitored on long term stability.
➢ Process Revalidation:
The major change in process will require for revalidation of the critical parameters to show
that it does not affect product quality. The process will be revalidated in case there is known
changes. For example: formula, critical equipment, critical process parameters, batch size, site
and change in vendor for API. The critical parameters identified in the prospective or
concurrent validation will be monitored during revalidation. The number of the batches to be
studied will depend on the nature of change for which study is planned. In case there is no
change in process, re-validation shall be carried out once in 6 years.
➢ This should be performed to provide documented evidence that the procedure being followed
for cleaning of equipment and accessories is effective and removes residues of previous
batch/ product up to a predetermined acceptance level, using a well-defined protocol and
acceptance criteria.
➢ There is one method employed for sampling during cleaning validation. That is swab/rinse
method.
➢ Cleaning procedures for products and processes, which are similar, do not need to be
individually validated.
➢ A representative of similar range can be selected to justify a validation programme, which
addresses the critical issues relating to selected products and processes.
➢ A single validation study under consideration of the ‘Worst case’ can be carried out which
takes into account the relevant criteria. Presently we are doing Cleaning verification for
product by swab/rinse method. Incoming year we will perform cleaning in a systematic way.
6.8 Revalidation:
➢ Revalidation is done to evaluate the impact of changes in process, product, systems,
computers (software), environment, intentionally or un-intentionally.
➢ The re-validation process is intended to ensure that validated systems continue to perform in
accordance with the parameters defined during the original validation.
➢ All systems subject to validation should be revalidated within a pre-specified period of time.
The re-validation frequency will be determined upon completion of the initial validation of a
system.
6.9 Revalidation after change is done in the following circumstances:
➢ Major changes in processing steps Eg.: Critical process parameters, input materials, batch
size.
➢ Major change in equipment size, design, construction and its material of fabrication.
➢ Major change in area and support system.
➢ Major change in Quality Control Analytical Methods.
➢ Major change in Computer – Software and Hardware.
6.10 Water System Validation:
PharmaZonner
QUALITY ASSURANCE DEPARTMENT
➢ Water system includes pretreatment of source water, generation of purified water, and
distribution of purified water.
➢ DQ, IQ and OQ of the water generation system shall be done in accordance with user
requirement and as specified in the equipment qualification.
➢ After qualification of generation system performance qualification of water system shall be
done.
Performance Qualification of water system shall be divided in three parts named as Phase-I,
phase-II and phase-III.
6.16 Sterilizing and Depyrogenating tunnel: It is used for sterilization and depyrogenation of glass
Containers (Vials and ampoules).
6.17 Nitrogen: Nitrogen generation system is made up of self diagnostic property and nitrogen is
used in different processes during manufacturing of products.
6.18 Analytical Method Validation:
All the Non- Pharmacopoeial analytical methods used in analysis at different stages of product
shall be validation as per recommendations of ICH. Typical validation characteristics which
should be considered area listed below:
Accuracy
Precision
Specificity
Detection limit
Quantitation Limit
Linearity
Range
6.19 Risk Assessment: Consists of the identification of hazards and the analysis and evaluation of
risks associated with exposure to those hazards (as defined below). Quality risk assessments
begin with a well-defined problem description or risk question. When the risk in question is well
defined, an appropriate risk management tool and the types of information needed to address the
risk question will be more readily identifiable. As an aid to clearly defining the risk(s) for risk
assessment purposes, three fundamental questions are often helpful:
➢ What might go wrong?
➢ What is the likelihood (probability) it will go wrong?
➢ What are the consequences (severity)?
6.20 Calibration/Verification Policy:
➢ Calibration is done in two ways i.e. In-house calibration of instruments which can be
performed at site and calibration done by external agency.
➢ Calibration of few instruments for which written procedure is available at the site are
calibrated by qualified personnel at site by predefined written procedure.
PharmaZonner
QUALITY ASSURANCE DEPARTMENT
➢ Agreement is done with external agency for the instruments and gauges which cannot be
calibrated at the site.
➢ Master calibration plan is prepared and all internal and external calibrations are performed
as per the master calibration plan.
➢ For some instruments there is policy of verification against the certified standards.
➢ Traceability for all standards shall be available at the site.
➢ All certified standards are recertified by government agency after span of time as per the
scheduled.
➢ Certified standards shall only be used within date of certification.
➢ All the work related to engineering operations shall be carried out by engineering
department.
➢ All the analytical work involved in the validation shall be carried out by quality control
Department.
➢ The activities related to issuance and dispensing of the material shall be taken care by
Warehouse.
➢ Progress of validation activity and the compliance shall be monitored by validation Team.
➢ Final report of validation activity shall be prepared by QA with the help of user
Department.
6.24 Annexure-I for Validation Master Plan preparation.
6.25 The Header part of VMP shall contains following details:
6.25.1 Company Logo, Validation Master plan, Company Name, Document No., supersedes no. and
Page No.
6.26 Validation Master Plan shall contain the following content:
6.26.1 Approval Page
6.26.2 Introduction of the Document
6.26.3 Purpose
6.26.4 Scope
6.26.5 Responsibilities
6.26.6 Definition
6.26.7 Validation Master plan
6.26.8 Facility Description
6.26.9 Validation Policy
6.26.10 Revalidation Policy
6.26.11 Equipment Qualification
6.26.12 Facility Qualification
6.26.13 Process Validation Plan
6.26.14 Cleaning Validation Plan
6.26.15 Water System Qualification
6.26.16 HVAC System Validation
PharmaZonner
QUALITY ASSURANCE DEPARTMENT
7.0 ABBREVIATIONS:
QA Corporate Quality Assurance
EHS Environment, Health & Safety
NA Not Applicable
No. Number
PDF Portable Document Format
QA Quality Assurance
QC Quality Control
Sign Signature
SOP Standard Operating Procedure
VMP Validation Master Plan
8.0 ANNEXURES:
ANNEXURE No. TITLE OF ANNEXURE FORMAT No.
Annexure– I Validation Master Plan preparation
10.0 REFERENCE:
➢ In-House, PIC/S VMP guidelines, WHO (TRS No. 937, 2006), Annex 4, Supplementary
guidelines on good manufacturing practices: validation.
➢ As per SOP title good documentation practice.
Annexure-I
VALIDATION MASTER PLAN PREPARATION
Prepared By:
Name Designation Sign & Date
Executive-Quality Assurance
Checked By:
Name Designation Sign & Date
Executive-QA/Assistant Manager QA
Approved By:
Name Designation Sign & Date
Head QA
P
Annexure-II
WEIGHING BALANCE CALIBRATION PLANNER
S.No. Weighing Balance I.D. Location Capacity Least Calibration Done Calibration Due
count date
Jan Feb March April May June July Aug Sep Oct Nov Dec
Approved By
Head-QA
(Sign/Date)
QUALITY ASSURANCE DEPARTMENT
Annexure-III
INSTRUMENT CALIBRATION PLANNER
S.No. Name of Instrument Location Instrument ID Frequency Calibration Done date Calibration Due date
Approved By
Head-QA
(Sign/Date)
PfiARMA DEVILS
QUALITY ASSURANCE DEPARTMENT
Annexure-IV
EQUIPMENT VALIDATION PLANNER
S.No. Name of Equipment Location Equipment ID Frequency Validation Done date Validation Due date
Approved by
Head QA
Sign/Date
P
QUALITY ASSURANCE DEPARTMENT
Annexure-V
AHU VALIDATION PLANNER
S.No. AHU No AHU ID Location Frequency Validation Done date Validation Due date
Approved By
Head-QA
(Sign/Date)